Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 1, 2016
Effect of an Early Switch to Belatacept Among Calcineurin Inhibitor-Intolerant Graft Recipients of Kidneys From Extended-Criteria DonorsY Le Meur, F Aulagnon, D Bertrand, et al.
Transplantation Proceedings|September 19, 2006
Long-term results of monoclonal anti-Il2-receptor antibody versus polyclonal antilymphocyte antibodies as induction therapy in renal transplantationA Al Najjar, I Etienne, P Le Pogamp, et al.
Pharmacological Research|October 6, 2009
Feasibility of, and critical paths for mycophenolate mofetil Bayesian dose adjustment: pharmacological re-appraisal of a concentration-controlled versus fixed-dose trial in renal transplant recipientsA Prémaud, A Rousseau, Y Le Meur, et al.
Transplantation Proceedings|September 14, 2011
The influence of cytomegalovirus infections on patient and renal graft outcome: a 3-year, multicenter, observational study (Post-ECTAZ Study)R Abou-Ayache, M Büchler, P Le Pogamp, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 21, 2010
High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF StudyF Martinez, N Kamar, N Pallet, et al.
Clinical Pharmacology and Therapeutics|June 5, 2009
UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF/tacrolimus-treated kidney transplant patientsR H N van Schaik, M van Agteren, J W de Fijter, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 18, 2007
Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroidsM Büchler, S Caillard, S Barbier, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 9, 2009
Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept studyY Lebranchu, A Thierry, O Toupance, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 19, 2016
Long-Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 GenotypeN Pallet, I Etienne, M Buchler, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 22, 2009
Interstitial fibrosis quantification in renal transplant recipients randomized to continue cyclosporine or convert to sirolimusA Servais, V Meas-Yedid, O Toupance, et al.
Pageof 5